Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1

被引:196
|
作者
Platt, Emily J. [2 ]
Bilska, Miroslawa
Kozak, Susan L. [2 ]
Kabat, David [2 ]
Montefiori, David C. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Surg, Lab AIDS Vaccine Res & Dev, Durham, NC 27710 USA
[2] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA
关键词
AMINO-ACID TRANSPORTER; C INFECTION; RETROVIRUSES; EXPRESSION; RECEPTOR; HIV-1; IDENTIFICATION; INTERFERENCE; EPITOPE; FUSION;
D O I
10.1128/JVI.00709-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The TZM-bl cell line that is commonly used to assess neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) was recently reported to be contaminated with an ecotropic murine leukemia virus (MLV) (Y. Takeuchi, M. O. McClure, and M. Pizzato, J. Virol. 82: 12585-12588, 2008), raising questions about the validity of results obtained with this cell line. Here we confirm this observation and show that HIV-1 neutralization assays performed with a variety of serologic reagents in a similar cell line that does not harbor MLV yield results that are equivalent to those obtained in TZM-bl cells. We conclude that MLV contamination has no measurable effect on HIV-1 neutralization when TZM-bl cells are used as targets for infection.
引用
收藏
页码:8289 / 8292
页数:4
相关论文
共 27 条
  • [1] Differential Inhibition of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells and TZM-bl Cells by Endotoxin-Mediated Chemokine and Gamma Interferon Production
    Geonnotti, Anthony R.
    Bilska, Miroslawa
    Yuan, Xing
    Ochsenbauer, Christina
    Edmonds, Tara G.
    Kappes, John C.
    Liao, Hua-Xin
    Haynes, Barton F.
    Montefiori, David C.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (03) : 279 - 291
  • [2] Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1
    Nandi, Avishek
    Lavine, Christine L.
    Wang, Pengcheng
    Lipchina, Inna
    Goepfert, Paul A.
    Shaw, George M.
    Tomaras, Georgia D.
    Montefiori, David C.
    Haynes, Barton F.
    Easterbrook, Philippa
    Robinson, James E.
    Sodroski, Joseph G.
    Yang, Xinzhen
    VIROLOGY, 2010, 396 (02) : 339 - 348
  • [3] Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression
    Piantadosi, Anne
    Panteleeff, Dana
    Blish, Catherine A.
    Baeten, Jared M.
    Jaoko, Walter
    McClelland, R. Scott
    Overbaugh, Julie
    JOURNAL OF VIROLOGY, 2009, 83 (19) : 10269 - 10274
  • [4] Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection
    Saunders, Kevin O.
    Wang, Lingshu
    Joyce, M. Gordon
    Yang, Zhi-Yong
    Balazs, Alejandro B.
    Cheng, Cheng
    Ko, Sung-Youl
    Kong, Wing-Pui
    Rudicell, Rebecca S.
    Georgiev, Ivelin S.
    Duan, Lijie
    Foulds, Kathryn E.
    Donaldson, Mitzi
    Xu, Ling
    Schmidt, Stephen D.
    Todd, John-Paul
    Baltimore, David
    Roederer, Mario
    Haase, Ashley T.
    Kwong, Peter D.
    Rao, Srinivas S.
    Mascola, John R.
    Nabel, Gary J.
    JOURNAL OF VIROLOGY, 2015, 89 (16) : 8334 - 8345
  • [5] Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and moloney murine leukemia virus reverse transcriptase
    Gao, HQ
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) : 1097 - 1113
  • [6] Phosphorylation of mouse SAMHD1 regulates its restriction of human immunodeficiency virus type 1 infection, but not murine leukemia virus infection
    Wang, Feifei
    Gelais, Corine St.
    de Silva, Suresh
    Zhang, Hong
    Geng, Yu
    Shepard, Caitlin
    Kim, Baek
    Yount, Jacob S.
    Wu, Li
    VIROLOGY, 2016, 487 : 273 - 284
  • [7] Development of a Norovirus P Particle Platform for Eliciting Neutralizing Antibody Responses to the Membrane Proximal External Region of Human Immunodeficiency Virus Type 1 Envelope
    Zang, Yang
    Bi, Jinpeng
    Du, Dongchuan
    Liu, Xintao
    Zhang, Yan
    Su, Weiheng
    Wu, Jiaxin
    Shan, Yaming
    Wang, Song
    Kong, Wei
    Qiu, Aidong
    Jiang, Chunlai
    PROTEIN AND PEPTIDE LETTERS, 2014, 21 (12) : 1230 - 1239
  • [8] Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope
    Menendez, A
    Chow, KC
    Pan, OCC
    Scott, JK
    JOURNAL OF MOLECULAR BIOLOGY, 2004, 338 (02) : 311 - 327
  • [9] Balancing Reversion of Cytotoxic T-Lymphocyte and Neutralizing Antibody Escape Mutations within Human Immunodeficiency Virus Type 1 Env upon Transmission
    Peut, Viv
    Campbell, Shahan
    Gaeguta, Adriana
    Center, Rob J.
    Wilson, Kim
    Alcantara, Sheilajen
    Fernandez, Caroline S.
    Purcell, Damian F. J.
    Kent, Stephen J.
    JOURNAL OF VIROLOGY, 2009, 83 (17) : 8986 - 8992
  • [10] Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model
    Rollman, Erik
    Mathy, Nathalie
    Brave, Andreas
    Boberg, Andreas
    Kjerrstrom, Anne
    van Wely, Cathy
    Engstrom, Gunnel
    Johansson, Susanne
    Aperia, Kajsa
    Eriksson, Lars E.
    Benthin, Reinhold
    Ertl, Peter
    Heeney, Jonathan
    Hinkula, Jorma
    Voss, Gerald
    Wahren, Britta
    VACCINE, 2007, 25 (11) : 2145 - 2154